A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world.
A trial led by The George Institute for Global Health revealed that most patients – 70 per cent – reached blood pressure targets with the ‘Triple Pill’, compared to just over half receiving normal care.
"I am a research assistant and PhD candidate, currently conducting research looking at gender differences in dietary intake and health outcomes at a population level, to identify if there is a need for gender sensitive food policy."
New South Wales Minister for Health and Medical Research The Hon Brad Hazzard has announced Ellen Medical Devices, the developer of The George Institute’s affordable dialysis system, as a recipient of a grant from the 2018 NSW Medical Devices Fund.
Director of Research Strategy and Services, Peter Dolnik, represented The George Institute at an important roundtable discussion as part of the Inquiry into Australia’s Research Funding on 7 August in Sydney.